FindTrial
Sign In

comparing two technique with local anesthetic medication using usg machine for post operative pain relive in caesarean section patients

Comparision Of usg guided post lscs Illioinguinal & Illiohypogastric nerve block and infiltration for analgesia after cesarian section -A prospective randomize control study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/042266
Enrollment
120
Registered
2022-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Post cesarean analgesia: Inj.ropivacin 0.5% 20 ml Through USG guided block or infiltration for post cesarean analgesia Control Intervention1: USG guided illionguinal and iliohypogastric

Sponsors

Goverment medical college Vadodara
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.singleton,full term pregnancy 2. ASA Physical status â?? I,II and III 3. scheduled for elective and emergency LSCS under spinal anaesthesia

Exclusion criteria

Exclusion criteria: 1.Patients refusal and not able to understand study protocol. 2.Patients who are hypersensitivity to local anaesthetic drug. 3.Contraindication to spinal anaesthesia. Severe PIH 4.Patients with compromised renal and liver function, uncontrolled diabetes severe 5.cardiovascular and respiratory disease. 6.Infection, trauma, scar or sinuses at site of illionguinal- iliohypogastric block 7.Patients with allergy to Infupar injection.

Design outcomes

Primary

MeasureTime frame
To assess analgesic efficacy of ultrasonography guided bilateral illionguinal- iliohypogastric nerve block for post operative pain after caesarean section by â?¢ comparing pain score â??visual analogue score â?¢ Total analgises consumption of illionguinal- iliohypogastric block group with that of control group. Timepoint: Baseline (just after shifted to USG room) During procedure At 15, 30, 45, and 60minute. At 2, 4, 6, 8, 12, 18, 24hour—

Secondary

MeasureTime frame
1)To Monitor Hemodynamic parameter in both groups. [PR, BP, SPO2] 2)Any side effects due to drug or procedureTimepoint: Baseline (just after shifted to USG room) During procedure At 15, 30, 45, and 60minute. At 2, 4, 6, 8, 12, 18, 24hour—

Countries

India

Contacts

Public ContactDr Mayurkumar Trivedi

Baroda medical College

drswatibhatt2015@yahoo.com6355626482

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026